Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity.

Crosswhite PL, Podsiadlowska JJ, Curtis CD, Gao S, Xia L, Srinivasan RS, Griffin CT.

J Clin Invest. 2016 Jun 1;126(6):2254-66. doi: 10.1172/JCI84652. Epub 2016 May 3.

2.

Treatment of adult hyper-IgD syndrome with canakinumab.

Curtis CD, Fox CC.

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):817-8. doi: 10.1016/j.jaip.2015.05.020. Epub 2015 Jun 25. No abstract available.

PMID:
26116953
3.

The NuRD chromatin-remodeling enzyme CHD4 promotes embryonic vascular integrity by transcriptionally regulating extracellular matrix proteolysis.

Ingram KG, Curtis CD, Silasi-Mansat R, Lupu F, Griffin CT.

PLoS Genet. 2013;9(12):e1004031. doi: 10.1371/journal.pgen.1004031. Epub 2013 Dec 12.

4.

BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development.

Davis RB, Curtis CD, Griffin CT.

Development. 2013 Mar;140(6):1272-81. doi: 10.1242/dev.087379. Epub 2013 Feb 13.

5.

Chromatin-remodeling complex specificity and embryonic vascular development.

Curtis CD, Davis RB, Ingram KG, Griffin CT.

Cell Mol Life Sci. 2012 Dec;69(23):3921-31. doi: 10.1007/s00018-012-1023-4. Epub 2012 May 23. Review.

6.

The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling.

Curtis CD, Griffin CT.

Mol Cell Biol. 2012 Apr;32(7):1312-20. doi: 10.1128/MCB.06222-11. Epub 2012 Jan 30.

7.

The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels.

Griffin CT, Curtis CD, Davis RB, Muthukumar V, Magnuson T.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2282-7. doi: 10.1073/pnas.1013751108. Epub 2011 Jan 24.

8.

Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues.

Curtis CD, Thorngren DL, Nardulli AM.

BMC Cancer. 2010 Jan 11;10:9. doi: 10.1186/1471-2407-10-9.

9.

Long-range transcriptional control of progesterone receptor gene expression.

Bonéy-Montoya J, Ziegler YS, Curtis CD, Montoya JA, Nardulli AM.

Mol Endocrinol. 2010 Feb;24(2):346-58. doi: 10.1210/me.2009-0429. Epub 2009 Dec 1.

10.

Apurinic/apyrimidinic endonuclease 1 alters estrogen receptor activity and estrogen-responsive gene expression.

Curtis CD, Thorngren DL, Ziegler YS, Sarkeshik A, Yates JR, Nardulli AM.

Mol Endocrinol. 2009 Sep;23(9):1346-59. doi: 10.1210/me.2009-0093. Epub 2009 May 21.

11.

Using RNA interference to study protein function.

Curtis CD, Nardulli AM.

Methods Mol Biol. 2009;505:187-204. doi: 10.1007/978-1-60327-575-0_11.

12.
13.

Resource availability controls fungal diversity across a plant diversity gradient.

Waldrop MP, Zak DR, Blackwood CB, Curtis CD, Tilman D.

Ecol Lett. 2006 Oct;9(10):1127-35.

14.

DNA methylation analysis in human cancer.

Curtis CD, Goggins M.

Methods Mol Med. 2005;103:123-36. Review.

PMID:
15542902
15.

A novel estrogen receptor alpha-associated protein alters receptor-deoxyribonucleic acid interactions and represses receptor-mediated transcription.

Loven MA, Davis RE, Curtis CD, Muster N, Yates JR, Nardulli AM.

Mol Endocrinol. 2004 Nov;18(11):2649-59. Epub 2004 Aug 12.

PMID:
15308690
16.

Molecular characterization of Cephalothorax, the Tribolium ortholog of Sex combs reduced.

Curtis CD, Brisson JA, DeCamillis MA, Shippy TD, Brown SJ, Denell RE.

Genesis. 2001 May;30(1):12-20.

PMID:
11353513
17.

Metal transport in a stream polluted by acid mine drainage--The Afon Goch, Anglesey, UK.

Boult S, Collins DN, White KN, Curtis CD.

Environ Pollut. 1994;84(3):279-84.

PMID:
15091699

Supplemental Content

Loading ...
Support Center